11
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Cannabis sativa ( CS, family Cannabinaceae) has been reported for its anti-emetic activity against cancer chemotherapy-induced emesis in animal models and in clinics. The current study was designed to investigate CS for potential effectiveness to attenuate cisplatin-induced vomiting in healthy pigeons and to study the impact on neurotransmitters involved centrally and peripherally in the act of vomiting. High-performance liquid chromatography system coupled with electrochemical detector was used for the quantification of neurotransmitters 5-hydroxytryptamine (5HT), dopamine (DA) and their metabolites; Di-hydroxy Phenyl Acetic acid (Dopac), Homovanillic acid (HVA), and 5-hydroxy indole acetic acid (5HIAA) centrally in specific brain areas (area postrema and brain stem) while, peripherally in small intestine. Cisplatin (7 mg/kg i.v.) induce emesis without lethality across the 24 h observation period. CS hexane fraction ( CS-HexFr; 10 mg/kg) attenuated cisplatin-induced emesis ∼ 65.85% ( P < 0.05); the reference anti-emetic drug, metoclopramide (MCP; 30 mg/kg), produced ∼43.90% reduction ( P < 0.05). At acute time point (3 rd h), CS-HexFr decreased ( P < 0.001) the concentration of 5HT and 5HIAA in the area postrema, brain stem and intestine, while at 18 th h (delayed time point) CS-HexFr attenuated ( P < 0.001) the upsurge of 5HT caused by cisplatin in the brain stem and intestine and dopamine in the area postrema. CS-HexFr treatment alone did not alter the basal neurotransmitters and their metabolites in the brain areas and intestine except 5HIAA and HVA, which were decreased significantly. In conclusion the anti-emetic effect of CS-HexFr is mediated by anti-serotonergic and anti-dopaminergic components in a blended manner at the two different time points, i.e., 3 rd and 18 th h in pigeons.

          Related collections

          Most cited references49

          • Record: found
          • Abstract: found
          • Article: not found

          Cannabinoid pharmacology: the first 66 years.

          Research into the pharmacology of individual cannabinoids that began in the 1940s, several decades after the presence of a cannabinoid was first detected in cannabis, is concisely reviewed. Also described is how this pharmacological research led to the discovery of cannabinoid CB(1) and CB(2) receptors and of endogenous ligands for these receptors, to the development of CB(1)- and CB(2)-selective agonists and antagonists and to the realization that the endogenous cannabinoid system has significant roles in both health and disease, and that drugs which mimic, augment or block the actions of endogenously released cannabinoids must have important therapeutic applications. Some goals for future research are identified.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            Chemotherapy-induced nausea and vomiting.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              An update on PPAR activation by cannabinoids.

              Some cannabinoids activate the different isoforms of PPARs (α, β and γ), as shown through the use of reporter gene assays, binding studies, selective antagonists and knockout studies. Activation of all isoforms, but primarily PPARα and γ, mediates some (but not all) of the analgesic, neuroprotective, neuronal function modulation, anti-inflammatory, metabolic, anti-tumour, gastrointestinal and cardiovascular effects of some cannabinoids, often in conjunction with activation of the more traditional target sites of action such as the cannabinoid CB1 and CB2 receptors and the TRPV1 ion channel. PPARs also mediate some of the effects of inhibitors of endocannabinoid degradation or transport. Cannabinoids may be chaperoned to the PPARs by fatty acid binding proteins. The aims of this review are to update the evidence supporting PPAR activation by cannabinoids and to review the physiological responses to cannabinoids that are mediated, and not mediated, by PPAR activation.
                Bookmark

                Author and article information

                Contributors
                Journal
                Front Pharmacol
                Front Pharmacol
                Front. Pharmacol.
                Frontiers in Pharmacology
                Frontiers Media S.A.
                1663-9812
                16 March 2018
                2018
                : 9
                : 231
                Affiliations
                [1] 1Department of Pharmacy, University of Swabi , Swabi, Pakistan
                [2] 2Department of Pharmacy, University of Peshawar , Peshawar, Pakistan
                [3] 3Drug and Herbal Research Centre, Faculty of Pharmacy, University Kebangsaan Malaysia , Kuala Lumpur, Malaysia
                [4] 4Department of Pharmacy, University of Malakand , Chakdara, Pakistan
                Author notes

                Edited by: Fabricio A. Pamplona, Entourage Phytolab, Brazil

                Reviewed by: Maria Grazia Morgese, University of Foggia, Italy; Daniel Souza Monteiro De Araújo, Federal Fluminense University, Brazil

                This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology

                Article
                10.3389/fphar.2018.00231
                5865282
                03ee110e-ce55-4829-add9-050099b55914
                Copyright © 2018 Ullah, Subhan, Alam, Shahid and Ayaz.

                This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

                History
                : 29 November 2017
                : 28 February 2018
                Page count
                Figures: 4, Tables: 4, Equations: 0, References: 57, Pages: 10, Words: 0
                Categories
                Pharmacology
                Original Research

                Pharmacology & Pharmaceutical medicine
                cisplatin,emesis,cannabis sativa,pigeon,neurotransmitters
                Pharmacology & Pharmaceutical medicine
                cisplatin, emesis, cannabis sativa, pigeon, neurotransmitters

                Comments

                Comment on this article